Abstract
[This corrects the article DOI: 10.7759/cureus.13002.].
Highlights
Erratum: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
The following statement in table 3 has been corrected as it erroneously stated that the product label has a black box warning for constipation
"A retrospective study from October 2018 to January 2020 evaluated 119 patients who took a CGRP mAb. Some monoclonal antibodies such as erenumab caused constipation in more than 20% of the patients and carries a black box warning."
Summary
Erratum: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines Shah 3 , Prachi Balani 4 , Angel R.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
